Dinesh Srinivasan

Dinesh Srinivasan

Auto-generated profile, based on publicly available information

Dinesh Srinivasan

Hoffman La-Roche, Nutley, NJ, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
JBJaspreet Banga
Jaspreet Banga
DSDinesh Srinivasan
Dinesh Srinivasan
CSChia-Chi Sun
Chia-Chi Sun
CTCherrie D. Thompson
Cherrie D. Thompson
FMFrancesca Milletti
Francesca Milletti
BBBetsy J Barnes
Betsy J Barnes
The transcription factor interferon regulatory factor 5 (IRF5) plays essential roles in pathogen-induced immunity downstream of Toll-, nucleotide-binding oligomerization domain–, and retinoic acid–inducible gene I–like receptors and is an autoimmune susceptibility gene. Normally, inactive in the cytoplasm, upon stimulation, IRF5 undergoes posttranslational modification(s), homodimerization, and nuclear translocation, where dimers mediate proinflammatory gene transcription. Here, we report the rational design of cell-penetrating peptides (CPPs) that disrupt IRF5 homodimerization. Biochemical and imaging analysis shows that IRF5-CPPs are cell permeable, noncytotoxic, and directly bind to endogenous IRF5. IRF5-CPPs were selective and afforded cell type– and species-specific inhibition. In plasmacytoid dendritic cells, inhibition of IRF5-mediated interferon-α production corresponded to a dose-dependent reduction in nuclear phosphorylated IRF5 [p(Ser462)IRF5], with no effect on pIRF5 levels. These data support that IRF5-CPPs function downstream of phosphorylation. Together, data support the utility of IRF5-CPPs as novel tools to probe IRF5 activation and function in disease.

10 July 2025 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
MRMatthew R Rice
Matthew R Rice
BMBharati Matta
Bharati Matta
LWLoretta Wang
Loretta Wang
QLQi Luo
Qi Luo
JGJeremy De Guzman
Jeremy De Guzman
BBBetsy J Barnes
Betsy J Barnes
The transcription factor interferon regulatory factor 5 (IRF5) functions as an important mediator of the inflammatory response downstream of MyD88-dependent TLRs. Whereas dysregulation of IRF5 activity has been implicated in the development of numerous autoimmune diseases including systemic lupus erythematosus, the factors that modulate TLR-induced IRF5 post-translational modifications are poorly understood. The focus of this study was to identify novel kinases in TLR-MyD88-IRF5 signaling. We performed a kinome-wide siRNA screen in human THP-1 monocytic cells and identified serine/threonine protein kinase 25 (STK25) as a positive regulator of pro-inflammatory cytokine production via phosphorylation of IRF5 at Thr265, leading to IRF5 transcriptional activation. We further found that STK25 undergoes autophosphorylation in response to multiple TLR triggers. Findings were validated in Stk25-deficient primary immune cells revealing a significant attenuation in R848-induced IRF5 nuclear translocation and pro-inflammatory cytokine production. Finally, we detected increased levels of STK25 autophosphorylation in immune cells from systemic lupus erythematosus donors compared with healthy controls. These findings implicate STK25 as a new regulator of TLR7/8 signaling through the modulation of IRF5 activation.